stocktools
Offerings // Outlook Therapeutics, Inc.

OTLK offering history

Every offering-related filing in Outlook Therapeutics, Inc.’s recent SEC record — registrations (announced capacity) kept separate from pricing documents (executed sales). Reviewed 833 filings back to Aug 10, 2015.

Last executed offering
Aug 14, 2026
424B5 — priced deal (shares or notes)
Last registration (announced)
Jul 17, 2026
S-3 — capacity, not a sale
Executed, last 12 months
8
424B pricings + 8-K 3.02 sales
Registered, last 12 months
1
S-1/S-3/F-series registrations
DateFilingWhat it means
Aug 14, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 12, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Jul 21, 2026424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Jul 21, 2026EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Jul 17, 2026S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 29, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 13, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 23, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 23, 20268-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Mar 25, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Mar 23, 2026424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 23, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 22, 2025424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
May 14, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 14, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 28, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 28, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 20, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 7, 2025424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Mar 7, 2025EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Feb 28, 2025S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Jan 31, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 16, 20258-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
May 6, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
May 6, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 26, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Apr 15, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Apr 12, 2024424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Apr 5, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Apr 1, 2024424B3 →UPDATEProspectus update — often a resale registration, not necessarily new capital
Apr 1, 2024EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Mar 28, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 25, 2024S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
Mar 18, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Jan 24, 20248-K →EXECUTEDUnregistered share sale disclosed (8-K item 3.02)
Aug 25, 2023424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Aug 25, 2023EFFECT →EFFECTIVESEC declared a registration effective — selling can begin
Aug 14, 2023S-3 →REGISTEREDS-3 registration — capacity to sell shares, not a sale yet
May 16, 2023424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
Dec 23, 2022424B5 →EXECUTEDShelf takedown priced — shares or notes (small-caps: usually shares; open the filing to confirm)
OTLK offering-related filings from SEC EDGAR, newest first (capped at 40). Each links to the original document.

Two honest limits. (1) A 424B takedown can price shares or notes — EDGAR’s metadata doesn’t say which, so open the document: large investment-grade filers use these mostly for bond deals (no dilution), small-caps mostly for shares. (2) At-the-market (ATM) programs sell shares gradually and individual sales are not separately filed — the visible footprint is the enabling shelf and its 424B5; actual ATM share counts surface later in the 10-Q/10-K share count. Educational information from public filings, not investment advice.

Is a shelf active now? →Do they need money? →Red flags →Full OTLK workspace →
OTLK offering FAQ

When did OTLK last execute an offering?

Per SEC filings, Outlook Therapeutics, Inc.'s most recent priced offering document is a 424B5 filed 2026-08-14. Note a 424B takedown can price shares or notes (debt) — the linked document says which.

When did OTLK last announce or register an offering?

The most recent registration is a S-3 filed 2026-07-17. A registration is capacity to sell shares — not a sale.

Does an offering always mean dilution?

Registered direct offerings and shelf takedowns issue new shares and dilute existing holders. Resale registrations (424B3/B7) let existing holders sell and do not create new shares. Secondary sales by insiders also do not dilute. Each row here is labeled with what it is.

Free to use. No account, no card.